Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 9/1/1995


1.		Phase I/II Study of R-VPAM/DOX for Recurrent Sarcomas (Summary Last Modified 09/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				any age				NCI				CCF-IRB-1105 NCI-T94-0167D, T94-0167

Last Modified: 5/3/2007


2.		Phase I/II Study of R-Verapamil with EPOCH (VP-16/PRED/VCR/CTX/DOX), with Analysis of Drug Resistance Mechanisms, in Relapsed/Refractory Lymphomas and Pediatric Sarcomas and of EPOCH Alone in Previously Untreated HIV-Associated Lymphomas (Summary Last Modified 01/96)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				at least 1 year				NCI				NCI-90-C-0113E NCI-MB-255, NCI-T90-0047N, T90-0047

Last Modified: 6/1/1995


3.		Phase II Study of Paclitaxel with the Multidrug Resistance Modulator Dexverapamil for Metastatic Breast Cancer (Summary Last Modified 06/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				TCINJ-940-1529 NCI-T94-0122O, T94-0122

Last Modified: 1/1/1995


4.		Phase II Study of VBL with Dexverapamil for Metastatic Renal Cell Cancer (Summary Last Modified 01/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 18								MSKCC-91120 NCI-V92-0024

Last Modified: 6/1/1993


5.		Phase II Pilot Study of Continuous-Infusion VIDA (VP-16/IDA/ARA-C) with or without R-Verapamil in Patients with Secondary AML or DeNovo AML in Relapse (Summary Last Modified 06/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NCI-92-C-0241 NCI-MB-296, NCI-T92-0085N, T92-0085

Last Modified: 11/1/1994


6.		Phase I Study of TAX with R-VPAM and G-CSF in Patients with Previously Treated, Metastatic Breast Cancer (Summary Last Modified 11/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				NCI-92-C-0245K NCI-MB-301, NCI-T92-0118N, T92-0118

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute